We thank Barbara W. Johnson and Marc Fischer for their helpful discussions about this study and Ginger Townsend for support in facilitating its implementation. We also thank the clinical study team for their dedication and work with special recognition to Pushpa Ranjan Wijesinghe, M. R. Nihal Abeysinghe, Sutee Yoksan, Yafu Yao, Benli Zhou, Lei Zhang, Mansour Yaich, Kathleen Neuzil, and John C. Victor.
Heffelfinger JD 2017. Japanese encephalitis surveillance and immunization - Asia and western Pacific regions, 2016. MMWR Morb Mortal Wkly Rep 66: 579–583.
Herrmann KL, Drdman DD, 1995. Diagnosis by serologic assays. Lennette EH, Lennette DA, Lennette ET, eds. Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections, 7th edition. Washington, DC: American Public Health Association.
Murray KO, Garcia MN, Yan C, Gorchakov R, 2013. Persistence of detectable immunoglobulin M antibodies up to 8 years after infection with West Nile virus. Am J Trop Med Hyg 89: 996–1000.
Roehrig JT, Nash D, Maldin B, Labowitz A, Martin DA, Lanciotti RS, Campbell GL, 2003. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis 9: 376–379.
Prince HE, Tobler LH, Yeh C, Gefter N, Custer B, Busch MP, 2007. Persistence of West Nile virus-specific antibodies in viremic blood donors. Clin Vaccine Immunol 14: 1228–1230.
Edelman R, Schneider RJ, Vejjajiva A, Pornpibul R, Voodhikul P, 1976. Persistence of virus specific IgM and clinical recovery after Japanese encephalitis. Am J Trop Med Hyg 25: 733–738.
Chien YW, Liu ZH, Tseng FC, Ho TC, Guo HR, Ko NY, Ko WC, Perng GC, 2018. Prolonged persistence of IgM against dengue virus detected by commonly used commercial assays. BMC Infect Dis 18: 156.
Gibney KB, Edupuganti S, Panella AJ, Kosoy OI, Delorey MJ, Lanciotti RS, Mulligan MJ, Fischer M, Staples JE, 2012. Detection of anti-yellow fever virus immunoglobulin M antibodies at 3–4 years following yellow fever vaccination. Am J Trop Med Hyg 87: 1112–1115.
Sohn YM, Park MS, Rho HO, Chandler LJ, Shope RE, Tsai TF, 1999. Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants. Vaccine 17: 2259–2264.
Cha GW, Cho JE, Ju YR, Hong Y, Han MG, Lee W, Choi EY, Jeong YE, 2014. Comparison of four serological tests for detecting antibodies to Japanese encephalitis virus after vaccination in children. Osong Public Health Res Perspect 5: 286–291.
Monath TP 2002. Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections. Vaccine 20: 1004–1018.
Litzba N, Klade CS, Lederer S, Niedrig M, 2010. Evaluation of serological diagnostic test systems assessing the immune response to Japanese encephalitis vaccination. PLoS Negl Trop Dis 4: e883.
Bundo K, Igarashi A, Morita K, Hayashi K, 1983. Enzyme-linked immunosorbent assay on Japanese encephalitis virus VI. Antibody response in human vaccines. Trop Med 25: 23–25.
Wijesinghe PR, Abeysinghe MRN, Yoksan S, Yao Y, Zhou B, Zhang L, Yaich M, Neuzil KM, Victor JC, 2014. Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka. Vaccine 32: 4751–4757.
Hombach J, Solomon T, Kurane I, Jacobson J, Wood D, 2005. Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2–3 September, 2004. Vaccine 23: 5205–5211.
Martin DA, Muth DA, Brown T, Johnson AJ, Karabatsos N, Roehrig JT, 2000. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol 38: 1823–1826.
Jacobson JA, Hills SL, Winkler JL, Mammen M, Thaisomboonsuk B, Marfin AA, Gibbons RV, 2007. Evaluation of three immunoglobulin M antibody capture enzyme-linked immunosorbent assays for diagnosis of Japanese encephalitis. Am J Trop Med Hyg 77: 164–168.
Robinson JS, Featherstone D, Vasanthapuram R, Biggerstaff BJ, Desai A, Ramamurty N, Chowdhury AH, Sandhu HS, Cavallaro KF, Johnson BW, 2010. Evaluation of three commercially available Japanese encephalitis virus IgM enzyme-linked immunosorbent assays. Am J Trop Med Hyg 83: 1146–1155.
Johnson BW, Goodman CH, Jee Y, Featherstone DA, 2016. Differential diagnosis of Japanese encephalitis virus infections with the Inbios JE Detect™ and DEN Detect™ MAC-ELISA kits. Am J Trop Med Hyg 94: 820–828.
World Health Organization, 2007. Manual for the Laboratory Diagnosis of Japanese Encephalitis Virus Infection. Geneva, Switzerland: WHO. Available at: https://www.who.int/immunization/monitoring_surveillance/burden/laboratory/Manual_lab_diagnosis_JE.pdf. Accessed September 22, 2020.
World Health Organization, 2018. Vaccine-preventable Diseases Surveillance Standards. Japanese Encephalitis. Geneva, Switzerland: WHO. Available at: https://www.who.int/immunization/monitoring_surveillance/burden/vpd/standards/en/. Accessed September 22, 2020.
Burke DS, Nisalak A, Ussery MA, Laorakpongse T, Chantavibul S, 1985. Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis 151: 1093–1099.
Hills S, Dabbagh A, Jacobson J, Marfin A, Featherstone D, Hombach J, Namgyal P, Rani M, Solomon T; Japanese Encephalitis Core Working Group, 2009. Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance. BMC Infect Dis 9: 214.